Hypoglycemia (Locemia) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.

Hypoglycemia (Locemia) General Information

Description

A treatment for severe hypoglycemia in people with diabetes treated with insulin. The drug uses a proprietary glucagon nasal powder formulation that is delivered in an emergency situation using a single-use, ready-to-use device.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 8505 Chemin Dalton
  • Montreal, Quebec H4T CA
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hypoglycemia (Locemia) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Corporate Asset Purchase 09-Oct-2015 Completed
To view Hypoglycemia (Locemia)’s complete valuation and funding history, request access »

Hypoglycemia (Locemia) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Locemia Solutions Corporation Majority 000 0000 000000 0
To view Hypoglycemia (Locemia)’s complete investors history, request access »